Dr. Anthony Pauchi, leader of the Corona White House Task Force, says trials on people with the virus have shown proven results • The drug blocks an enzyme that the virus uses • "This is good news: there is a way to deal with the virus through drugs"
Has there been a breakthrough in the fight to eradicate the Corona? Anthony Fauchi, who is at the forefront of the U.S. anti-virus campaign as a director of the National Allergy and Infectious Diseases Institute, said Wednesday that an experiment on humans with an antiviral drug called remdesivir shows "clear results" in the ability to fight the virus. It is a drug originally developed for Ebola, but proven to be ineffective for it.
Photo: Ministry of Health
Although it is still early to say that there is one proven and effective way that it can be considered as a cure for the respiratory illness caused by the corona virus, Pauchi's remarks indicate that a plague drug can be developed in principle.
"The information indicates that the drug used in the experiment has a significant positive effect and is clearly shortened to recovery time," said Fauchi. "This is a very important feasibility proof. It's a feasibility proof that a drug can block the virus," he added.
Pauchi emphasized that the drug also had a positive effect on inhibiting the level of mortality: in the group receiving the drug, the mortality was lower than that of the control group, which received only placebo (a dummy drug). However, he said the difference in mortality was small and not statistically significant.
More on:
• In severe condition: A 16-year-old is hospitalized with suspicion of Corona
• It is final: the health statement at the entrance to the school
• Mitzi, Distance Keeping: Should cats stay away from fear of Corona?
According to him, although it is too early to declare the drug in question as a remedy beams, "This is the first real big experiment with a control group, not just the United States." According to Fauci, the treatment used in the experiment is now standard in the treatment of disease.
"What has been proven is that you can block The virus by a drug, which in this case blocks an enzyme that the virus uses. In the long term, this indicates that there is a way to deal with the virus through medication, so it can be said to be good news, "said Pawchi. The
company conducting the Gilead trial noted that over half of the patients receiving the drug were discharged from the hospital within 14 days, including over 60 percent receiving it. The drug is only for 5 days. However, the trial is not yet over.
Following the encouraging results of the remdesivir trial, the FDA (US Food and Drug Administration) intends to authorize emergency use of the drug as part of the fight in Corona, The New York Times reported today. This, although it usually takes months for a drug to get approved for use.